Spleen stiffness-based algorithms are superior to Baveno VI criteria to rule out varices needing treatment in patients With advanced chronic liver disease
Source
The American journal of gastroenterology - ISSN 0002-9270-119:8 (2024) p. 1515-1524
Metabolic dysfunction-associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction
Source
Gastroenterology - ISSN 0016-5085-167:2 (2024) p. 1-20
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Source
Cell death and differentiation - ISSN 1350-9047-31 (2024) p. 1113-1126
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
Source
Journal of hepatology - ISSN 0168-8278-81:5 (2024) p. 827-836
The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver disease
Source
International journal of obesity - ISSN 0307-0565-48:4 (2024) p. 512-522